Conventional health check-ups often focus on identifying existing conditions rather than understanding early indicators of biological ageing and future health risks. Vytalyou aims to address this gap through integrated diagnostics and personalised preventive health assessments.
Its core offering is the Predictive Longevity Evaluation, which brings together blood investigations, radiology, genomics, cardiovascular assessments and body-composition analysis. An AI-guided platform analyses health data to generate insights on biological age, metabolic health and potential risk areas, which doctors use to develop personalised wellness plans.
Proof
Vytalyou operates a doctor-supervised longevity centre in Powai, Mumbai, offering diagnostics, physician consultations and personalised IV wellness programmes. Its service portfolio also includes home-based IV therapy and sample collection, while several advanced modalities, including regenerative cell therapy and red-light therapy, are listed as upcoming services.
People
Founded by Dr. Chirantan Bose, a molecular oncologist, and Dr. Preetesh Bhandari, a radiologist, Vytalyou brings together expertise in molecular diagnostics, genomics, medical imaging and preventive healthcare. The founders lead the company's efforts to integrate clinical expertise with technology-led longevity services.
Purse
Vytalyou raised approximately ₹9 crore in a pre-Series A funding round in August 2026, at a reported valuation of around ₹33 crore. The investment came from Chetan Jain of Pharma Dose and Ratan Jain of Venus Industries to support its clinic expansion plans.
Plan
The company plans to expand its Mumbai presence from its existing Powai centre to three locations, with new centres planned in Juhu and Worli. It is also targeting expansion into other major Indian cities in 2027, with a longer-term ambition to build a network of 10 clinics across India.
Why it matters
Preventive healthcare is increasingly shifting towards early risk detection, personalised interventions and long-term health management. By bringing diagnostics, AI-guided assessments and physician-supervised wellness services together, Vytalyou is exploring an integrated model for India's emerging longevity healthcare market.
|
Particulars |
Details |
|---|---|
|
Company |
CBPB Diagnostic Services Private Limited |
|
Brand |
Vytalyou |
|
Inception |
September 2025 |
|
Headquarters |
Mumbai, Maharashtra |
|
Industry |
Preventive Healthcare, Longevity Science, Medical Diagnostics |
|
Founders |
Dr. Chirantan Bose and Dr. Preetesh Bhandari |
|
Core Offering |
Predictive Longevity Evaluation |
|
Key Services |
Diagnostics, Genomics, Body Composition Analysis, IV Therapy |
|
Technology |
AI-guided health and longevity assessment |
|
Funding |
Approximately ₹9 crore |
|
Funding Stage |
Pre-Series A |
|
Investors |
Chetan Jain (Pharma Dose) and Ratan Jain (Venus Industries) |
|
Reported Valuation |
Approximately ₹33 crore |
|
Website |
Disclaimer: This profile is based on publicly available company information.